AU2687901A - Association of deoxyfructosazine and a peroxisome proliferating gamma-activated receptor agonist antidiabetic - Google Patents

Association of deoxyfructosazine and a peroxisome proliferating gamma-activated receptor agonist antidiabetic

Info

Publication number
AU2687901A
AU2687901A AU26879/01A AU2687901A AU2687901A AU 2687901 A AU2687901 A AU 2687901A AU 26879/01 A AU26879/01 A AU 26879/01A AU 2687901 A AU2687901 A AU 2687901A AU 2687901 A AU2687901 A AU 2687901A
Authority
AU
Australia
Prior art keywords
deoxyfructosazine
antidiabetic
gamma
association
receptor agonist
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU26879/01A
Inventor
Michel Evers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Publication of AU2687901A publication Critical patent/AU2687901A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU26879/01A 1999-12-23 2000-12-16 Association of deoxyfructosazine and a peroxisome proliferating gamma-activated receptor agonist antidiabetic Abandoned AU2687901A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9916359 1999-12-23
FR9916359A FR2802815A1 (en) 1999-12-23 1999-12-23 Associations of deoxyfructosazine and a peroxisome-proliferating gamma-activated receptor agonist antidiabetic agent have a synergistic activity in the treatment of type 2 diabetes
PCT/FR2000/003606 WO2001047529A2 (en) 1999-12-23 2000-12-20 Association of deoxyfructosazine and an antidiabetic agonist of the peroxysome proliferator gamma-activated receptor

Publications (1)

Publication Number Publication Date
AU2687901A true AU2687901A (en) 2001-07-09

Family

ID=9553731

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26879/01A Abandoned AU2687901A (en) 1999-12-23 2000-12-16 Association of deoxyfructosazine and a peroxisome proliferating gamma-activated receptor agonist antidiabetic

Country Status (3)

Country Link
AU (1) AU2687901A (en)
FR (1) FR2802815A1 (en)
WO (1) WO2001047529A2 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2766183B1 (en) * 1997-07-17 1999-08-27 Rhone Poulenc Rorer Sa MEDICINES CONTAINING NEW POLYHYDROXYBUTYLPYRAZINES, NEW POLYHYDROXYBUTYLPYRAZINES AND THEIR PREPARATION

Also Published As

Publication number Publication date
FR2802815A1 (en) 2001-06-29
WO2001047529A3 (en) 2002-10-24
WO2001047529A2 (en) 2001-07-05

Similar Documents

Publication Publication Date Title
AU4336899A (en) Novel leukotriene receptor antagonists and their uses
AU5611000A (en) Co-sintering of similar materials
AU7653700A (en) New benzimidazolone derivatives having mixed serotonine and dopamine receptors affinity
AU6893000A (en) Digital id for selecting web browser and use preferences of a user during use ofa web application
AU5343298A (en) 5-ht2c receptor agonists and aminoalkylindazole derivatives
AU775774C (en) Peroxisome proliferator-activated receptor agonist
AU1926000A (en) Pth1r and pth3r receptors
HUP0101411A3 (en) A pharmaceutical preparation comprising an angiotensin ii type 2 receptor agonist, and use thereof
AU2327100A (en) Cement-based joint body and joint material therefor
AU2081999A (en) Pharmaceutical compostition comprising a compound having dopamine (D2) receptor agonist activity and a compound (B) having Beta2 adrenoreceptor agonist activity
IL138576A0 (en) A novel interleukin-1 receptor antagonist and uses thereof
AU6232300A (en) Receptors and associated proteins
AU1652601A (en) New combination comprising a beta2-adrenoreceptor agonist and a leukotriene receptor antagonist
AU1862295A (en) 5-ht3 receptor agonist, novel thiazole derivative, and intermediate therefor
AU781786C (en) Radioprotective materials and utilization thereof
AU2001225663A1 (en) A composition comprising a combination of receptor agonists and antagonists
AU5861900A (en) Receptor agonists and antagonists
AU2687901A (en) Association of deoxyfructosazine and a peroxisome proliferating gamma-activated receptor agonist antidiabetic
AU2847899A (en) Combination of a gaba-a alpha 5 inverse agonist and a muscarinic agonist
AU2001277963A1 (en) 65494, a human g-protein-coupled receptor family member and uses thereof
AU1698899A (en) N-acetylserotonin derivatives and uses thereof
AU3935897A (en) B1-bradykinin receptor antagonists and use thereof
AU2001280969A1 (en) 18610, a human transient receptor and uses thereof
AU2001286877A1 (en) 57242, a novel human g protein-coupled receptor family member and uses therefor
AU2288801A (en) 2871 receptor, a g-protein coupled receptor and methods of use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase